nefrНефрологияNephrology (Saint-Petersburg)1561-62742541-9439Pavlov First Saint-Petersburg State Medical University10.24884/1561-6274-2013-17-1-98-101nefr-541Research ArticleНАБЛЮДЕНИЯ ИЗ ПРАКТИКИPRACTICAL NOTESПОРАЖЕНИЕ ПОЧЕК ПРИ СОЧЕТАНИИ МЕТАБОЛИЧЕСКОГО СИНДРОМА И ПОДАГРЫ В ПОЖИЛОМ ВОЗРАСТЕRENAL IRRITATION AT A COMBINATION OF METABOLIC SYNDROME AND GOUT AT ELDERLY PATIENTSКуницкаяН. А.KunitskayaN. A.

Кафедра геронтологии и гериатрии 

193015, Санкт-Петербург, ул. Кирочная, д. 41

scvssd@yandex.ruСеверо-Западный государственный медицинский университет им. И.И. МечниковаRussian Federation20131001201317198101Copyright © Куницкая Н.А., 20132013Куницкая Н.А.Kunitskaya N.A.Данная работа распространяется под лицензией Creative Commons Attribution 4.0.This work is licensed under a Creative Commons Attribution 4.0 License.https://journal.nephrolog.ru/jour/article/view/541

Подагра и метаболический синдром – широко распространенные заболевания настоящего времени, особенно в пожилом возрасте. Подагра часто характеризуется поражением почек. На клиническом примере рассмотрены типичные вопросы, возникающие при диагностике гиперурикемии и подагры.

Gout and metabolic syndrome are widespread diseases of the present, especially at elderly patients. Gout is often characterized by renal irritation. On a clinical example the typical questions arising at diagnostics of hyperuricemia and gout are considered.

подаграпочкиметаболический синдромпожилой возрастgoutkidneysmetabolic syndromeelderly ageReferencesJin M, Yang F, Yang I et al. Uric acid, hyperuricemia and vascular diseases. Front Biosci 2012; 17:656-669Jin M, Yang F, Yang I et al. Uric acid, hyperuricemia and vascular diseases. Front Biosci 2012; 17:656-669Ichikawa N, Taniguchi A, Urano W et al. Comorbidities in patients with gout. Nucleosides Nucleotides Nucleic Acids 2011; 30(12):1045-1050Ichikawa N, Taniguchi A, Urano W et al. Comorbidities in patients with gout. Nucleosides Nucleotides Nucleic Acids 2011; 30(12):1045-1050Chen HS. Clinical implications of the metabolic syndrome and hyperuricemia. J Chin Med Assoc 2011;74(12):527-528Chen HS. Clinical implications of the metabolic syndrome and hyperuricemia. J Chin Med Assoc 2011;74(12):527-528Bhansing KJ, Bon L, Janssen M et al. Gout: a clinical syndrome illustrated and discussed. Nether J Med 2010; 68(9): 352-359Bhansing KJ, Bon L, Janssen M et al. Gout: a clinical syndrome illustrated and discussed. Nether J Med 2010; 68(9): 352-359Dore RK. The gout diagnosis. Clev Clin J Med 2008; 75: 17-21Dore RK. The gout diagnosis. Clev Clin J Med 2008; 75: 17-21Lawrence RC, Felson DT, Helmick CG et al. Estimates of the prevalence of arthritis and other rheumatic conditions in the United States. Arthritis Rheum 2008; 58: 26–35Lawrence RC, Felson DT, Helmick CG et al. Estimates of the prevalence of arthritis and other rheumatic conditions in the United States. Arthritis Rheum 2008; 58: 26–35Caspi D, Lubart E, Graff E et al The effect of mini-dose aspirin on renal function and uric acid handling in elderly patients. Arthritis Rheum 2000; 43: 103–108Caspi D, Lubart E, Graff E et al The effect of mini-dose aspirin on renal function and uric acid handling in elderly patients. Arthritis Rheum 2000; 43: 103–108Аbdelrahman M, Rafi A, Ghacha R et al. Hyperuricemia and gout in renal transplant recipients. Ren Fail 2002; 24: 361–367Аbdelrahman M, Rafi A, Ghacha R et al. Hyperuricemia and gout in renal transplant recipients. Ren Fail 2002; 24: 361–367

The authors declare that there are no conflicts of interest present.